Stock Market Watch

BioClinica – BIOC – eClinical Solutions from BioClinica Accelerate in Europe

by ·


BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, is quickly becoming the eClinical provider of choice for European pharmaceutical, medical device, biotechnology and contract research organizations (CROs). BioClinica’s combination of nimble programing, scalability, ease of use, and high value are winning the attention of European companies tired of outdated, slow-moving, cumbersome eClinical systems.

As clinical trials become increasingly global in nature, there is a growing call for software solutions and services that get trials up and running faster with less cost. BioClinica is answering this need with a full range of industry-leading eClinical products, solutions, and services that help launch and manage studies with a minimum of effort at a cost far below those typically associated with such high levels of functionality.

European-based contracts are not new for BIOC and have historically accounted for a significant portion of sales. Clients range from global pharmaceutical and medical device companies to large and small CROs. BIOC’s recent European projects include the deployment of multiple eClinical solutions such as Optimizer, OnPoint CTMS, Trident IWR, and Express EDC, as well as world-class Data Management services.


With European headquarters in Leiden, The Netherlands, as well as offices in Lyon, France, BIOC not only has the technology to support European customers, but also the dedicated resources on the continent to support the adoption and deployment of our technology. BIOC is also adding skilled positions to support its growing business expectations.

“European trial sponsors are really seeing the difference compared to the ‘one-size-fits-all’ providers,” said Peter Benton, BioClinica’s president of eClinical Solutions. “BioClinica specializes in clinical trial solutions, and our products are built to easily conform to each individual study rather than forcing the study to fit into a mold. Our various solutions, such as OnPoint CTMS, Trident IWR, and Express EDC integrate with each other to help get studies running quickly and efficiently.”

BIOC’s products are recognized for the “Office Smart” capabilities which harness the power of SharePoint and the Microsoft Office Suite to provide study project managers a comprehensive, real-time view into trial performance. This allows pharmaceutical, biotech, and medical device manufacturers to leverage their existing investments in Microsoft Office to better interact with their trial data, reduce the training timeline, and get studies up and running faster.

About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, Microsoft Office-Smart clinical trial management, and clinical supply chain forecasting and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.

More Posts by this author

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...